Description
Added on the 29/07/2020 18:03:28 - Copyright : Euronews EN
Jerusalem, Aug 1 (EFE / EPA) .- Israel began Sunday to inject the third dose of the Covid-19 vaccine to adults over 60 years of age, after starting this inoculation phase on Friday with President Isaac Herzog and a small number of people.(Camera: ATEF SAFADI)SHOT LIST: VACCINATION DRIVE FOR THE THIRD JAB FOR ADULTS OVER 60 IN JERUSALEM, ISRAEL.
Moscow, Apr 5 (EFE), (Camera EPA/EFE Archive).- The Russian Direct Investment Fund on Monday announced an agreement with the Indian Panacea Biotec to produce 100 million annual doses of the Sputnik V coronavirus vaccine.The deal would allow RDIF to provide its international partners with the jab, the Russian sovereign fund said in a statement.India is one of the first countries Russia has approached to manufacture the vaccine, approved by 59 countries.ARCHIVE FOOTAGE OF MOSCOW AND COVID-19VACCINATION IN INDIA.
London (United Kingdom), Jan 21 (EFE), (Camera: Clàudia Sacrest).- The United Kingdom reported Thursday that it has already administered more than five million doses of the vaccine against covid-19 since it began its immunization campaign in early December.FOOTAGE OF THE LONDON BRIDGE CENTRE 1 VACCINATION CENTER, AND GUY'S HOSPITAL IN CENTRAL LONDON.
Shanghai, Jan 4 (EFE/EPA).- Fosun Pharma, a Chinese listed pharmaceutical company, and Germany's BioNTech reported in December that they would supply Mainland China with 100 million doses of a COVID-19 vaccine in 2021, after regulatory approval. In March 2020, Shanghai-based pharmaceutical company Fosun Pharma made a purchase agreement with BioNTech to buy 50 million USD worth of stock. It became a strategic partner in developing and producing the mRNA vaccine. (Camera: ALEX PLAVEVSKI).SHOT LIST: THE FOSUN PHARMA HEADQUARTERS BUILDING IN SHANGHAI, CHINA.
On Wednesday, Pfizer and BioNTech announced having reached a deal with the U.S. government with an additional 100 million doses by July 31. That's up from the initial 100 million doses ordered already. The deal follows a similar extension of doses reached by the U.S. with Moderna for their vaccine. Both vaccines require two doses to be administered. The $2 billion deal calls for at least an additional 70 million doses to be provided to the U.S. by June 30. The remaining 30 million doses needing to be delivered by July 31. It also allows for the U.S. to obtain up to an additional 400 million doses in the future.
|
Support : Technical 
- Content 
- Editors 
